摘要 |
<p>The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit RNA-containing virus, particularly the Hepatitis C Virus (HCV). Consequently, the compounds of the present invention interfere with the life cycle of the Hepatitis C Virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.</p> |
申请人 |
ENANTA PHARMACEUTICALS, INC. |
发明人 |
QIU, YAO-LING;WANG, CE;CAO, HUI;PENG, XIAOWEN;TANG, DATONG;OR, YAT, SUN |